Skip to main content
. 2017 Dec 16;44(1):1–12. doi: 10.1136/bmjsrh-2017-101825

Table 4.

Multivariate poisson regression models evaluating factors associated with evaluating consistent condom use and condom use at last coitus for female and male participants

Consistent condom use (past month) Use at last coitus
Female Male Female Male
(APRs (95% CI)) (APRs (95% CI)) (APRs (95% CI)) (APRs (95% CI))
Age 1.01 (0.98 to 1.04)
Education
  Some secondary or less 1
  Completed secondary or more 1.20 (0.94 to 1.51)
Catholic
  Yes 1 1
  No 1.50 (0.89 to 2.52) 1.18 (0.86 to 1.61)
 Years since diagnosis 1.01 (0.99 to 1.04)
Use of alcohol or drugs before/during sex in last month
 No 1 1
 Yes 0.82 (0.60 to 1.11) 0.99 (0.81 to 1.20)
Sexual frequency in last month
 ≤weekly 1 1 1 1
 >1 x/week 0.79 (0.62 to 1.00) 0.96 (0.76 to 1.22) 0.87 (0.72 to 1.05) 0.90 (0.76 to 1.05)
Currently using ART
  No 1
 <2 years 1.31 (0.85 to 2.02)
 ≥2 years 1.52 (1.03 to 2.23)*
Desire more children in the future
 No 1 1 1 1
 Yes 0.69 (0.51 to 0.93)* 0.84 (0.57 to 1.24) 0.74 (0.59 to 0.93)* 0.95 (0.75 to 1.20)
Most recent sexual partner HIV-positive
  Yes 0.89 (0.70 to 1.13) 0.87 (0.67 to 1.13) 1.27 (0.96 to 1.70) 0.88 (0.75 to 1.03)
  No 1 1 1 1
  I do not know 0.66 (0.42 to 1.03) 0.59 (0.28 to 1.24) 1.24 (0.52 to 1.51) 0.66 (0.41 to 1.08)
Believe one needs to use a condom if using also birth control method
 No 1 1 1 1
 Yes 1.09 (0.80 to 1.48) 1.88 (1.16 to 3.05)* 1.08 (0.84 to 1.39) 1.24 (0.96 to 1.60)
Can refuse sex if partner did not want to use a condom
 No 1 1 1 1
 Yes 4.33 (2.72 to 6.90)* 2.77 (1.68 to 4.58)* 2.27 (1.74 to 2.95)* 1.70 (1.28 to 2.27)*
Decision-making about using condom use
 I do 1 1 1 1
 My partner does 1.34 (0.88 to 2.04) 0.89 (0.56 to 1.41) 1.28 (0.96 to 1.70) 0.81 (0.59 to 1.11)
 We both do 1.50 (1.15 to 1.97)* 0.98 (0.77 to 1.26) 1.24 (1.02 to 1.51)* 0.93 (0.80 to 1.10)

The prevalence ratios presented are adjusting for all variables with results included in the table for the specific gender and outcome.

*P<0.05.

APRs, adjusted prevalence ratios; ART, antiretroviral therapy CI , CI interval.